Squarepoint’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21,334
| Closed | -$113K | – | 4720 |
|
|
2025
Q3 | $113K | Buy |
21,334
+3,540
| +20% | +$15K | ﹤0.01% | 4086 |
|
|
2025
Q2 | $61K | Buy |
+17,794
| New | +$56.8K | ﹤0.01% | 4276 |
|
|
2025
Q1 | – | Sell |
-75,929
| Closed | -$232K | – | 5201 |
|
|
2024
Q4 | $232K | Sell |
75,929
-23,318
| -23% | -$67.8K | ﹤0.01% | 4358 |
|
|
2024
Q3 | $253K | Buy |
99,247
+27,856
| +39% | +$84.3K | ﹤0.01% | 3559 |
|
|
2024
Q2 | $233K | Buy |
71,391
+10,757
| +18% | +$47.2K | ﹤0.01% | 3571 |
|
|
2024
Q1 | $321K | Buy |
60,634
+32,236
| +114% | +$174K | ﹤0.01% | 3333 |
|
|
2023
Q4 | $123K | Sell |
28,398
-28,180
| -50% | -$93.4K | ﹤0.01% | 3717 |
|
|
2023
Q3 | $149K | Sell |
56,578
-34,409
| -38% | -$117K | ﹤0.01% | 3491 |
|
|
2023
Q2 | $321K | Buy |
90,987
+74,137
| +440% | +$231K | ﹤0.01% | 2925 |
|
|
2023
Q1 | $52.1K | Sell |
16,850
-1,043
| -6% | -$3.93K | ﹤0.01% | 3050 |
|
|
2022
Q4 | $75.7K | Buy |
+17,893
| New | +$61.7K | ﹤0.01% | 2996 |
|
|
2022
Q1 | – | Sell |
-38,201
| Closed | -$116K | – | 3349 |
|
|
2021
Q4 | $116K | Sell |
38,201
-61,156
| -62% | -$265K | ﹤0.01% | 2883 |
|
|
2021
Q3 | $696K | Buy |
99,357
+22,431
| +29% | +$168K | ﹤0.01% | 1776 |
|
|
2021
Q2 | $706K | Buy |
76,926
+37,226
| +94% | +$377K | ﹤0.01% | 1881 |
|
|
2021
Q1 | $386K | Sell |
39,700
-14,428
| -27% | -$161K | ﹤0.01% | 2221 |
|
|
2020
Q4 | $555K | Buy |
54,128
+34,425
| +175% | +$349K | ﹤0.01% | 1740 |
|
|
2020
Q3 | $199K | Buy |
19,703
+3,045
| +18% | +$31K | ﹤0.01% | 2096 |
|
|
2020
Q2 | $174K | Buy |
+16,658
| New | +$172K | ﹤0.01% | 1866 |
|
|
2020
Q1 | – | Sell |
-130,773
| Closed | -$1.14M | – | 2348 |
|
|
2019
Q4 | $1.14M | Sell |
130,773
-39,154
| -23% | -$324K | 0.01% | 1249 |
|
|
2019
Q3 | $1.83M | Sell |
169,927
-18,225
| -10% | -$197K | 0.02% | 885 |
|
|
2019
Q2 | $2.39M | Buy |
188,152
+158,862
| +542% | +$3.66M | 0.02% | 749 |
|
|
2019
Q1 | $1.14M | Sell |
29,290
-1,475
| -5% | -$45K | 0.01% | 1038 |
|
|
2018
Q4 | $626K | Sell |
30,765
-9,426
| -23% | -$283K | 0.01% | 1140 |
|
|
2018
Q3 | $1.84M | Buy |
+40,191
| New | +$1.94M | 0.02% | 757 |
|
|
2018
Q1 | – | Sell |
-10,626
| Closed | -$1.05M | – | 2022 |
|
|
2017
Q4 | $1.05M | Buy |
10,626
+1,955
| +23% | +$219K | 0.02% | 809 |
|
|
2017
Q3 | $1.04M | Sell |
8,671
-14,263
| -62% | -$1.33M | 0.02% | 712 |
|
|
2017
Q2 | $2M | Buy |
22,934
+171
| +0.8% | +$9.57K | 0.04% | 516 |
|
|
2017
Q1 | $847K | Sell |
22,763
-1,371
| -6% | -$50K | 0.02% | 668 |
|
|
2016
Q4 | $741K | Buy |
24,134
+20,430
| +552% | +$883K | 0.03% | 623 |
|
|
2016
Q3 | $248K | Buy |
+3,704
| New | +$187K | 0.02% | 814 |
|
|
2015
Q3 | – | Sell |
-9,627
| Closed | -$1.12M | – | 536 |
|
|
2015
Q2 | $1.12M | Buy |
+9,627
| New | +$1.74M | 0.36% | 71 |
|
Other funds holding PBYI
ACA
OSAM
Squarepoint's PBYI Position: Q4 2025 in Review
Squarepoint sold out of Puma Biotechnology (PBYI) in Q4 2025, closing a stake of 21,334 shares — an estimated $113K sold.
Squarepoint first reported a position in PBYI in Q2 2015 and held it in 31 quarters. The position peaked at $2.39M in Q2 2019. 151 funds tracked by Wall St. Rank hold PBYI as of Q4 2025.
- Squarepoint reported no remaining Puma Biotechnology position as of Q4 2025 after selling out during the quarter.
- Squarepoint sold 21,334 Puma Biotechnology shares in Q4 2025, an estimated $113K.
- Squarepoint first reported a position in Puma Biotechnology in Q2 2015 and held it in 31 quarters.
- Squarepoint's Puma Biotechnology position peaked at $2.39M in Q2 2019.
- 151 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2025.
Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.